Tyrosine Kinase Screening Library

Tyrosine kinases (TKs) belong to a relatively complex class of enzymes that emerged at an early stage of evolution, and are involved in phosphorylation and dephosphorylation of proteins together with protein phosphatases. TKs are key molecules in signaling pathways and important targets in drug discovery. There are two types of tyrosine kinases in cells: receptor tyrosine kinases and non-receptor tyrosine kinases. The main roles of TKs include regulation of multicellular functions of the body. Intercellular signals related to growth, differentiation, adhesion, motility, and death are usually transmitted via tyrosine kinases. Tyrosine kinases are attractive biological targets for cancer therapy because their abnormal signaling is often associated with tumor development and growth.

BOC Sciences can design a new tyrosine kinase screening library containing approximately 5,700 drug-like screening compounds for high-throughput screening (HTS).

Tyrosine Kinase Screening Library Design

  1. Firstly, approximately 150,000 reference compounds with known TKs blocking activity are obtained from a variety of commercial databases
  2. Then, these compounds are initially filtered to retain only those with moderate and high activity against TKs
  3. In the next step, we perform a 2D fingerprint similarity search against the reference set to analyze the BOC Sciences HTS compound collection
  4. Finally, the compounds obtained will be further filtered using Lipinski's Rule of Five to deliver only drug-like ones. In addition, PAINS compounds and compounds with reactive groups are removed from the library

At BOC Sciences, the generated potential tyrosine kinase inhibitors possess activity against the following targets:

  • ALK tyrosine kinase receptor
  • Tyrosine-protein kinase ITK/TSK
  • Discoidin domain-containing receptor 2 (Tissues remodeling TK)
  • Tyrosine-protein kinase JAK1
  • Dual specificity protein kinase TTK
  • Tyrosine-protein kinase JAK2
  • Dual specificity tyrosine-phosphorylation-regulated kinase 1A
  • Tyrosine-protein kinase JAK3
  • Dual-specificity tyrosine-phosphorylation regulated kinase 1A
  • Tyrosine-protein kinase LCK
  • Dual-specificity tyrosine-phosphorylation regulated kinase 3
  • Tyrosine-protein kinase Lyn
  • Ephrin type-A receptor 2 (Receptor TK)
  • Tyrosine-protein kinase receptor FLT3
  • Ephrin type-A receptor 4 (Receptor TK)
  • Tyrosine-protein kinase receptor RET
  • Ephrin type-B receptor 3 (Receptor TK)
  • Tyrosine-protein kinase receptor TYRO3
  • Ephrin type-B receptor 4 (Receptor TK)
  • Tyrosine-protein kinase receptor UFO
  • Epidermal growth factor receptor erbB1 (Receptor TK)
  • Tyrosine-protein kinase SRC
  • Epithelial discoidin domain-containing receptor 1 (Receptor TK)
  • Tyrosine-protein kinase SYK
  • Fibroblast growth factor receptor 1 (Receptor TK)
  • Tyrosine-protein kinase TIE-2
  • Hepatocyte growth factor receptor (Receptor TK)
  • Tyrosine-protein kinase TXK
  • Vascular endothelial growth factor receptor 1 (Receptor TK)
  • Tyrosine-protein kinase YES
  • Macrophage-stimulating protein receptor (Receptor TK)
  • Tyrosine-protein kinase ZAP-70
  • Maternal embryonic leucine zipper kinase (non-membrane TK activity)
  • Leukocyte tyrosine kinase receptor
  • Nerve growth factor receptor Trk-A (Receptor TK)
  • Protein tyrosine kinase 2 beta
  • Neurotrophic tyrosine kinase receptor type 2
  • Tyrosine kinase non-receptor protein 2
  • NT-3 growth factor receptor (Receptor TK) (Receptor TK)
  • Tyrosine-protein kinase ABL
  • Vascular endothelial growth factor receptor 2
  • Tyrosine-protein kinase BTK
  • Proto-oncogene tyrosine-protein kinase MER
  • Tyrosine-protein kinase CSK
  • Receptor protein-tyrosine kinase erbB-2
  • Tyrosine-protein kinase FER
  • Stem cell growth factor receptor (Receptor TK)
  • Tyrosine-protein kinase FES
  • Interferon-induced, double-stranded RNA-activated protein kinase
  • Tyrosine-protein kinase FYN
  • (non-membrane spanning protein tyrosine kinase activity)
  • Tyrosine-protein kinase TYK2

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors.  Figure 1. A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors. (Lotz-Jenne, C.; et al. 2016)

Tyrosine Kinase Screening Library Characteristics

  • High diversity over the screening set: mean Tanimoto > 0.85
  • Favorable physicochemical parameters and solubility requirements
  • No PAINS or toxic substances/unwanted functions: filtered by strict ‘Ro5-like’ physicochemical and most stringent in-house structural filters
  • Bioactivity and safety confirmed by preclinical studies and clinical trials
  • Structural diversity, medicinal activity, and cellular penetration
  • Structural document, IC50, and other chemical and biological data are provided
  • All compounds are continually updated
  • Compound cherry-picking service is provided

What We Deliver

  • Delivered within 2 weeks in any customer-preferred format
  • Powders, dry films or DMSO solutions formatted in vials, 96 or 384-well plates
  • All compounds have a minimum purity of 90% assessed by 1H NMR and HPLC
  • Analytical data is provided

BOC Sciences provides professional, rapid and high-quality services of Tyrosine Kinase Screening Library design at competitive prices for global customers. Personalized and customized services of Tyrosine Kinase Screening Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!

Reference

  1. Lotz-Jenne, C.; et al. A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor. Oncotarget. 2016. 7(18): 25983-26002.
Our mission is to provide clients with a professional chemical library design platform. Empowered by high-quality services and effective research solutions, we are committed to helping customers achieve effective and successful research goals.

Online Inquiry

Verification code
Services Based on the Chemical Library Design Platform

Services Based on the Chemical Library Design Platform

BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.

BACK TO TOP